Increased serum concentrations of transforming growth factor-β1 (TGF-β1) in patients with Guillain-Barré syndrome
详细信息 查看全文
- 作者：Kuo-Hsuan Chang ; Rong-Kuo Lyu ; Yen-Shi Ro ; Yi-Chun Chen ; Long-Sun Ro ; Hong-Shiu Chang ; Ching-Chang Huang ; Ming-Feng Liao ; Yih-Ru Wu ; Hong-Chou Kuo ; Chun-Che Chu ; Chiung-Mei Chen ; cmchen@cgmh.org.tw" class="auth_mail" title="E-mail the corresponding author
- 关键词：AD ; Alzheimer's disease ; AIDP ; acute inflammatory demyelinating polyneuropathy ; AMAN ; acute motor axonal neuropathy ; AMSAN ; acute motor and sensory axonal neuropathy ; CIDP ; chronic inflammatory demyelinating polyradiculoneuropathy ; CSF ; cerebrospinal fluid ; GBS ; Guillain-Barré ; syndrome ; IL-6 ; interleukin-6 ; INCAT disability scale ; inflammatory neuropathy cause and treatment disability scale ; MFS ; Miller-Fisher syndrome ; MS ; multiple sclerosis ; TGF-β1 ; transforming growth factor-β1 ; VCAM-1
- 刊名：Clinica Chimica Acta
- 出版年：2016
- 出版时间：1 October 2016
- 年：2016
- 卷：461
- 期：Complete
- 页码：8-13
- 全文大小：456 K
文摘
- •
Serum TGF-β1 level is higher in GBS compared with CIDP, MFS, MS, AD and controls.
- •
Serum TGF-β1 level is correlated with the degree of disability in GBS.
- •
Serum TGF-β1 level is a potential biomarker of GBS for disease severity.